Datasea Intelligent Technology Ltd. (DTSS) Stock Analysis and Metrics

Datasea Intelligent Technology

NASDAQ: DTSS

$0.76 ▲ +0.00 (+0.00%)

At close: Jul 8, 2026 · 2:33 PM UTC

Financial Ratios

Market Cap7.32 Mn

P/E-2.69

P/S0.13

Div. Yield0.00

Total Debt (Qtr)3.70 Mn

Revenue Growth (1y) (Qtr)-36.47

Add ratio to table…

About

Datasea Inc. is a technology company focused on the research development and commercialization of acoustic high tech and 5G+ AI multimodal digitalization solutions. It operates in the technology sector integrating acoustic technologies with artificial intelligence to create products and services for medical, industrial, and digital markets. The company’s core activities include developing acoustic based devices for health and environmental applications such as disinfection units, sleep aids, and therapeutic equipment. Through continuous investment in research and development Datasea has built a closed loop system that links technology innovation, product development, and market deployment.

Revenue is generated primarily from service fees for its 5G+ AI multimodal digital business which includes solution based projects such as e commerce platforms, digital rural services, new media marketing, and enterprise digital management. Additional revenue comes from the acoustic high tech segment through entrusted manufacturing of products like air purifiers and sleep aids, direct sales of acoustic intelligent devices, and limited renovation or ancillary service agreements. The company also earns income from licensing its software, from providing technical support and maintenance under long term contracts. Its customer base spans small and medium enterprises, large corporations, government agencies, and public institutions mainly located in China.

The company operates through the following segments: Acoustic High Tech and 5G+ AI Multimodal Digitalization.

• Acoustic High Tech: This segment develops and commercializes acoustic technologies such as ultrasound, infrasound, and directional sound combined with AI algorithms and sensing hardware for health related products like environmental disinfection units, sleep aids, and therapeutic equipment. It also focuses on industrial precision applications where ultrasonic assisted processing and AI driven parameter optimization are used to improve manufacturing accuracy and process consistency in sectors such as semiconductor processing, aerospace machining, and biomedical fabrication. The segment emphasizes system level integration rather than standalone devices aiming to provide scalable solutions that can be incorporated into medical robots, industrial automation, and smart healthcare platforms.

• 5G+ AI Multimodal Digitalization: This segment provides AI driven digital services that process text, voice, image, video, and structured data in real time under 5G conditions delivering solutions such as new media marketing platforms, digital rural services, enterprise digital management tools, and customized e commerce platforms for small and medium enterprises. The platform leverages Transformer based AI models and distributed computing to enable semantic understanding, content generation, and decision support across multiple data formats. It supports applications ranging from smart agriculture and financial data analysis to intelligent customer relationship management and targeted advertising campaigns. By focusing on high margin, solution oriented, and offerings the segment has improved profitability while maintaining scalability and repeatability for long term contracts.

Within the acoustic technology and AI enabled digital services markets Datasea positions itself as a niche innovator that combines acoustic sensing with AI to offer differentiated solutions not easily replicated by pure software or hardware providers. Its competitive advantages stem from a growing patent portfolio covering acoustic signal enhancement, brain computer interface techniques, and multimodal data processing as well as its focus on high margin, solution oriented, and offerings that have improved gross margins. The company also benefits from its deep understanding of local market needs in China where it has established relationships with numerous industry partners, research institutions, and government bodies. These factors enable Datasea to pursue targeted growth in high value niches while maintaining a disciplined approach to cost control and operational efficiency.

The company’s customer base includes specific partners such as Yuxiang Zhiyang Tianjin Innovation Technology Co Ltd, Anhui Gukai Business Co Ltd, Beijing Shuhai Culture Media Co Ltd, Hainan Taihe Ruixiang Technology Development Co Ltd, Beijing Meimei Partner Network Technology Co Ltd, He Yue Tianjin Cultural Media Co Ltd, Nanjing Linghang Intelligent Aviation Technology Co Ltd, and Shenzhen YiZhiMei Technology Co Ltd. In addition to these named clients Datasea serves a broad base of over 52 million businesses and households across China most of which are small and medium enterprises. Its digital solutions are also used by local service operators, financial institutions, and public sector agencies seeking to improve operational efficiency and data driven decision making. The acoustic products find adoption among health clinics, wellness centers, environmental service providers, and industrial manufacturers looking for advanced cleaning, sterilization, and precision processing capabilities.

Investment Thesis

▲ Bull case

Datasea has achieved an engineering level core technology in ultrasonic enhanced nanoscale precision control that is designed for next generation semiconductor manufacturing. This breakthrough reflects a systematic integration of ultrasonic enhancement with ultra precision composite manufacturing processes creating a systems level precision control architecture. The technology addresses the growing need for stability surface uniformity and nanoscale controllability as semiconductor nodes continue to shrink and process complexity rises. By positioning its acoustic architecture in high end industrial environments Datasea expands its addressable market beyond health and consumer applications opening a potential long term revenue stream from licensing joint development or equipment sales. The foundational nature of the work suggests scalability and durability of the underlying acoustic platform which could become a differentiated barrier in the advanced manufacturing equipment market.
Datasea has advanced its acoustic driven brain computer interface technology from foundational signal processing to engineering level system integration through collaborations with Nanjing Linghang and Guozhong Times. The company is developing two application streams one focused on assistive communication for neurological patients and another on upper limb rehabilitation robot control. These efforts aim to translate neural signals into stable control commands for external devices addressing variability in signal quality and the need for reliable human machine interaction in caregiving settings. A channel execution plan targets the deployment of up to ten thousand acoustic haircare robot units across health lifestyle venues and technical service cooperation arrangements providing a clear path to scale. By embedding acoustic algorithms sensing technologies and AI recognition models into partner hardware Datasea creates a full stack solution that can generate hardware sales technical service fees and recurring service linked revenues. The underlying market for beauty wellness and neurorehabilitation is described as multi billion dollar offering a sizable addressable opportunity for the company’s acoustic technology platform.
Datasea reported a year over year gross profit increase of approximately 284% and a gross margin expansion of about 730 basis points to 8.8% for the six month period ended December 31 2025. This improvement follows a deliberate shift away from low margin standardized services toward higher margin technology driven solution oriented revenue. Completed projects worth roughly RMB 6.9 million equivalent to about USD 1.01 million are expected to contribute strongly to gross profit validating the new business mix. Early stage deployments in the United States for acoustic technology enabled wellness care robots have begun generating technical service revenue demonstrating initial commercial traction. Management indicates that the current commercialization initiatives could deliver up to approximately ten million dollars of incremental revenue in the next fiscal year subject to execution and market conditions. The redomicile of the holding company to the British Virgin Islands may improve tax efficiency and provide additional flexibility for accessing international capital markets.
Datasea’s acoustic technology is being applied in distinct verticals including semiconductor manufacturing health robotics beauty and wellness devices and environmental hygiene products such as the Smart Air Sterilizer. This diversification creates multiple potential revenue streams that are not tightly correlated reducing the impact of a slowdown in any one sector. The company’s 5G AI multimodal digitalization segment continues to provide a stable base of higher margin customized solutions supporting overall profitability while the acoustic segment pursues growth. Strategic partnerships with firms that possess established channel networks such as Yizhimei and Nanjing Linghang enable Datasea to leverage existing sales infrastructure without bearing the full cost of building a direct go to market organization. The combination of a core technology platform with varied application scenarios enhances the company’s ability to cross sell and bundle solutions increasing customer stickiness and lifetime value. Such a diversified approach positions Datasea to capture value from multiple emerging trends rather than betting on a single narrow niche.
Datasea has built an expanding patent portfolio covering acoustic coupling real time closed loop vibration modulation and related neuromodulation techniques which underpins its technology barriers. These patents protect the core acoustic enhancement methods that improve EEG signal quality decoding stability and system reliability in brain computer interface applications. By securing intellectual property rights in both acoustic hardware and software layers the company raises the cost for competitors to replicate its integrated solutions. The technology framework is designed to be extensible allowing future upgrades such as additional sensor modalities or AI algorithms to be layered onto the existing acoustic base. This layered approach creates a moat that can sustain long term competitive advantage as the company expands into new application domains. Investors may benefit from the potential monetization of the IP through licensing or joint ventures beyond the current product rollout.

Datasea has achieved an engineering level core technology in ultrasonic enhanced nanoscale precision control that is designed for next generation semiconductor manufacturing. This breakthrough reflects a systematic integration of ultrasonic enhancement with ultra precision composite manufacturing processes creating a systems level precision control architecture. The technology addresses the growing need for stability surface uniformity and nanoscale controllability as semiconductor nodes continue to shrink and process complexity rises. By positioning its acoustic architecture in high end industrial environments Datasea expands its addressable market beyond health and consumer applications opening a potential long term revenue stream from licensing joint development or equipment sales. The foundational nature of the work suggests scalability and durability of the underlying acoustic platform which could become a differentiated barrier in the advanced manufacturing equipment market.
Datasea has advanced its acoustic driven brain computer interface technology from foundational signal processing to engineering level system integration through collaborations with Nanjing Linghang and Guozhong Times. The company is developing two application streams one focused on assistive communication for neurological patients and another on upper limb rehabilitation robot control. These efforts aim to translate neural signals into stable control commands for external devices addressing variability in signal quality and the need for reliable human machine interaction in caregiving settings. A channel execution plan targets the deployment of up to ten thousand acoustic haircare robot units across health lifestyle venues and technical service cooperation arrangements providing a clear path to scale. By embedding acoustic algorithms sensing technologies and AI recognition models into partner hardware Datasea creates a full stack solution that can generate hardware sales technical service fees and recurring service linked revenues. The underlying market for beauty wellness and neurorehabilitation is described as multi billion dollar offering a sizable addressable opportunity for the company’s acoustic technology platform.
Datasea reported a year over year gross profit increase of approximately 284% and a gross margin expansion of about 730 basis points to 8.8% for the six month period ended December 31 2025. This improvement follows a deliberate shift away from low margin standardized services toward higher margin technology driven solution oriented revenue. Completed projects worth roughly RMB 6.9 million equivalent to about USD 1.01 million are expected to contribute strongly to gross profit validating the new business mix. Early stage deployments in the United States for acoustic technology enabled wellness care robots have begun generating technical service revenue demonstrating initial commercial traction. Management indicates that the current commercialization initiatives could deliver up to approximately ten million dollars of incremental revenue in the next fiscal year subject to execution and market conditions. The redomicile of the holding company to the British Virgin Islands may improve tax efficiency and provide additional flexibility for accessing international capital markets.
Datasea’s acoustic technology is being applied in distinct verticals including semiconductor manufacturing health robotics beauty and wellness devices and environmental hygiene products such as the Smart Air Sterilizer. This diversification creates multiple potential revenue streams that are not tightly correlated reducing the impact of a slowdown in any one sector. The company’s 5G AI multimodal digitalization segment continues to provide a stable base of higher margin customized solutions supporting overall profitability while the acoustic segment pursues growth. Strategic partnerships with firms that possess established channel networks such as Yizhimei and Nanjing Linghang enable Datasea to leverage existing sales infrastructure without bearing the full cost of building a direct go to market organization. The combination of a core technology platform with varied application scenarios enhances the company’s ability to cross sell and bundle solutions increasing customer stickiness and lifetime value. Such a diversified approach positions Datasea to capture value from multiple emerging trends rather than betting on a single narrow niche.
Datasea has built an expanding patent portfolio covering acoustic coupling real time closed loop vibration modulation and related neuromodulation techniques which underpins its technology barriers. These patents protect the core acoustic enhancement methods that improve EEG signal quality decoding stability and system reliability in brain computer interface applications. By securing intellectual property rights in both acoustic hardware and software layers the company raises the cost for competitors to replicate its integrated solutions. The technology framework is designed to be extensible allowing future upgrades such as additional sensor modalities or AI algorithms to be layered onto the existing acoustic base. This layered approach creates a moat that can sustain long term competitive advantage as the company expands into new application domains. Investors may benefit from the potential monetization of the IP through licensing or joint ventures beyond the current product rollout.

▼ Bear case

Datasea’s ultrasonic enhanced nanoscale precision control technology remains in the research and engineering validation phase and has not yet entered commercialization. The timeline for moving from foundational research to a product ready for semiconductor fabrication equipment is uncertain and could extend several years. During this period the company will continue to incur research and development expenses without a corresponding revenue stream from this vertical. Success will depend on meeting the stringent tolerances reliability and contamination control standards demanded by leading fab equipment manufacturers. Any failure to satisfy these technical requirements could render the technology unsuitable for its target market and waste the invested R&D capital. Investors should therefore view the semiconductor opportunity as a long term speculative bet rather than a near term catalyst.
Much of Datasea’s near term revenue potential is tied to collaborations with a limited number of partners such as Yizhimei Nanjing Linghang and Guozhong Times. These alliances provide access to distribution channels customer bases and co development resources but also create concentration risk. If any partner experiences financial difficulties strategic shifts or decides to terminate the collaboration the company’s deployment plans could be delayed or scaled back. The revenue sharing and fee structures defined in the agreements may limit Datasea’s ability to capture the full upside of successful product rollouts. Building an independent direct sales force would require substantial investment and time which the company may not be able to afford given its current cash position. Consequently the company’s growth trajectory is highly sensitive to the stability and performance of its partnership network.
The adoption of acoustic driven health robots and brain computer interface devices depends on acceptance by healthcare providers patients and reimbursement bodies. Regulatory clearance for non invasive neuromodulation and medical device applications can be a lengthy costly process with no guarantee of approval. Competing technologies from established players in the BCI wellness robotics and medical device spaces may offer comparable or superior performance at lower cost. If reimbursement policies do not cover the use of these acoustic solutions demand could remain confined to niche private pay segments limiting volume. The company’s early stage deployments are still limited to a few hundred locations across China and a handful of U.S. sites providing limited evidence of broad market traction. Until larger scale clinical trials and real world outcome studies demonstrate clear benefits the market may remain skeptical of the technology’s value proposition.
Datasea intentionally reduced low margin standardized services causing a year over year decline in top line revenue while focusing on margin expansion. Although gross profit and margin have improved the company’s overall revenue base remains smaller than in prior periods which may limit its ability to absorb operating expenses. Continued pressure to grow revenue while maintaining higher margins could force the company to make trade offs between pricing volume and product mix. If the shift to higher margin solutions does not generate sufficient volume the company could face stagnating or declining gross profit despite margin gains. The business model transition carries execution risk as the company must win new customers for customized higher priced offerings amid a competitive environment. Investors should monitor whether the margin improvement can be sustained without a rebound in overall sales volume.
The company is investing heavily in research and development across multiple fronts including semiconductor acoustic technology BCI health robots and acoustic disinfection products. These R&D activities are accompanied by expenses for prototyping testing regulatory compliance and partnership management. While recent quarters have shown gross profit expansion the company has not disclosed detailed cash flow statements indicating whether operating cash generation covers its investment needs. If operating cash flow remains negative Datasea may need to rely on external financing which could lead to dilution of existing shareholders or increased debt burden. The redomicile to the British Virgin Islands while potentially beneficial for tax efficiency does not automatically improve liquidity and may raise questions about corporate governance transparency for some investors. A prolonged period of negative cash flow could constrain the company’s ability to pursue growth initiatives and increase vulnerability to market downturns.

Datasea’s ultrasonic enhanced nanoscale precision control technology remains in the research and engineering validation phase and has not yet entered commercialization. The timeline for moving from foundational research to a product ready for semiconductor fabrication equipment is uncertain and could extend several years. During this period the company will continue to incur research and development expenses without a corresponding revenue stream from this vertical. Success will depend on meeting the stringent tolerances reliability and contamination control standards demanded by leading fab equipment manufacturers. Any failure to satisfy these technical requirements could render the technology unsuitable for its target market and waste the invested R&D capital. Investors should therefore view the semiconductor opportunity as a long term speculative bet rather than a near term catalyst.
Much of Datasea’s near term revenue potential is tied to collaborations with a limited number of partners such as Yizhimei Nanjing Linghang and Guozhong Times. These alliances provide access to distribution channels customer bases and co development resources but also create concentration risk. If any partner experiences financial difficulties strategic shifts or decides to terminate the collaboration the company’s deployment plans could be delayed or scaled back. The revenue sharing and fee structures defined in the agreements may limit Datasea’s ability to capture the full upside of successful product rollouts. Building an independent direct sales force would require substantial investment and time which the company may not be able to afford given its current cash position. Consequently the company’s growth trajectory is highly sensitive to the stability and performance of its partnership network.
The adoption of acoustic driven health robots and brain computer interface devices depends on acceptance by healthcare providers patients and reimbursement bodies. Regulatory clearance for non invasive neuromodulation and medical device applications can be a lengthy costly process with no guarantee of approval. Competing technologies from established players in the BCI wellness robotics and medical device spaces may offer comparable or superior performance at lower cost. If reimbursement policies do not cover the use of these acoustic solutions demand could remain confined to niche private pay segments limiting volume. The company’s early stage deployments are still limited to a few hundred locations across China and a handful of U.S. sites providing limited evidence of broad market traction. Until larger scale clinical trials and real world outcome studies demonstrate clear benefits the market may remain skeptical of the technology’s value proposition.
Datasea intentionally reduced low margin standardized services causing a year over year decline in top line revenue while focusing on margin expansion. Although gross profit and margin have improved the company’s overall revenue base remains smaller than in prior periods which may limit its ability to absorb operating expenses. Continued pressure to grow revenue while maintaining higher margins could force the company to make trade offs between pricing volume and product mix. If the shift to higher margin solutions does not generate sufficient volume the company could face stagnating or declining gross profit despite margin gains. The business model transition carries execution risk as the company must win new customers for customized higher priced offerings amid a competitive environment. Investors should monitor whether the margin improvement can be sustained without a rebound in overall sales volume.
The company is investing heavily in research and development across multiple fronts including semiconductor acoustic technology BCI health robots and acoustic disinfection products. These R&D activities are accompanied by expenses for prototyping testing regulatory compliance and partnership management. While recent quarters have shown gross profit expansion the company has not disclosed detailed cash flow statements indicating whether operating cash generation covers its investment needs. If operating cash flow remains negative Datasea may need to rely on external financing which could lead to dilution of existing shareholders or increased debt burden. The redomicile to the British Virgin Islands while potentially beneficial for tax efficiency does not automatically improve liquidity and may raise questions about corporate governance transparency for some investors. A prolonged period of negative cash flow could constrain the company’s ability to pursue growth initiatives and increase vulnerability to market downturns.

Peer Comparison

Companies in the Software - Infrastructure

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	MSFT	Microsoft Corp	2,853.66 Bn	22.79	8.97	40.26 Bn
2	ORCL	Oracle Corp	408.21 Bn	23.92	6.06	122.34 Bn
3	PLTR	Palantir Technologies Inc.	300.98 Bn	131.24	57.61	-
4	PANW	Palo Alto Networks Inc	247.84 Bn	193.34	25.05	-
5	CRWD	CrowdStrike Holdings, Inc.	193.63 Bn	-1,201.41	40.24	0.75 Bn
6	FTNT	Fortinet, Inc.	117.45 Bn	60.08	16.52	0.50 Bn
7	NET	Cloudflare, Inc.	86.88 Bn	-1,001.47	37.31	1.29 Bn
8	SNPS	Synopsys Inc	86.18 Bn	1,416.99	10.76	10.04 Bn

Research Tools

Developers

About

Investment Thesis

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Peer Comparison

Create an account

Sign In

Reset Password